Skip to content

Analysis of Chlordecone Tissue Concentrations in Patients Treated for Thyroid Surgery at Guadeloupe University Hospital

Analysis of Chlordecone Tissue Concentrations in Patients Treated for Thyroid Surgery at Guadeloupe University Hospital

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07611994
Acronym
COTICHLO
Enrollment
69
Registered
2026-05-28
Start date
2026-07-01
Completion date
2027-11-01
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid and Parathyroid Surgery

Keywords

chlordecone, thyroid nodes, thyroid disruptor

Brief summary

Chlordecone, an organochlorine pesticide used in the French Caribbean for several decades, is recognized as an endocrine disruptor. Accumulation in thyroid tissue may be modeled using several factors, including blood chlordecone levels, environmental exposure associated with place of residence, and dietary habits.

Detailed description

Chlordecone, an organochlorine pesticide, is recognized as an endocrine disruptor. Following ingestion, this molecule is preferentially stored in the liver and, to a lesser extent, in adipose tissue. The development of thyroid goiter may be promoted by exposure to certain substances. Environmental pollutants have been shown to increase TSH secretion, and prolonged exposure to endocrine disruptors affecting the pituitary-thyroid axis has been associated with thyroid neoplasia. Currently, exposure to chlordecone is assessed through measurement of chlordeconemia (plasma concentration), reflecting exposure during the months preceding sampling and providing an estimate of body burden at the time of assessment. However, chlordecone impregnation in thyroid tissue and adjacent structures has not yet been investigated in humans. The aim of this study is to model chlordecone concentration in tissues using chlordeconemia, occupational activity, dietary habits, and place of residence. A biological collection will be established and stored at the Biological Resources Center (CRB) of the University Hospital to support the primary and secondary objectives. Blood, adipose tissue, and thyroid tissue samples will be collected. The inclusion period will last 11 months, each participant will be involved for 4 months, and the total study duration will be 16 months.

Interventions

OTHERBlood and thyroid tissue collection

Collection of blood, thyroid tissue, and adjacent adipose tissue samples during routine thyroid surgery for measurement of chlordecone concentration and assessment of exposure-related factors.

Sponsors

Centre Hospitalier Universitaire de la Guadeloupe
Lead SponsorOTHER
Institut Pasteur de Guadeloupe
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Observational, analytical, single-center, cross-sectional study with prospective data collection.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients hospitalized at the Guadeloupe University Hospital for surgical treatment of thyroid pathology * person affiliated to or beneficiaries of a social security system * person with free, informed, and written consent signed by the participant and the investigator

Exclusion criteria

* patients subject to a judicial safeguard measure, * patient under 18 years old * patient without signed consent * current pregnancy at the time of inclusion

Design outcomes

Primary

MeasureTime frameDescription
chlordecone concentration in the adipose tissue adjacent to the thyroidDuring surgeryChlordecone concentration measured in adipose tissue adjacent to the thyroid collected during thyroid surgery.
Chlordecone concentration in blood1 day before surgeryChlordecone concentration measured in blood samples collected one day before surgery.

Secondary

MeasureTime frameDescription
Occupational exposure categoryAt enrollmentOccupational activity classified as high or low potential exposure to chlordecone based on professional activity collected through a self-administered questionnaire. Agricultural workers and livestock breeders will be classified as high exposure occupations
Residential environmental exposure assessmentAt enrollmentEnvironmental exposure assessment based on residential history during the previous 10 years. Residential addresses reported for periods longer than 3 months will be geolocated and linked to soil contamination maps established by CIRAD.
Dietary exposure assessmentAt enrollmentDietary habits assessed using a self-administered questionnaire collecting information on food consumption patterns and food origin.

Countries

Guadeloupe

Contacts

CONTACTmélanie petapermal, Master degree
melanie.petapermal@chu-guadeloupe.fr+590590934667
PRINCIPAL_INVESTIGATORsuzy Duflo, MD PhD

CHU de la Guadeloupe

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026